P2RY2 is significantly expressed in prostate tumors, a cancer of the urinary tract, and inhibition of P2RY2 expression affects the epithelial-mesenchymal transition process of tumor cells and the expression of invasion-related genes, which subsequently affect the invasion and migration of tumor cells [52, 53]. This evidence concerns the gene P2RY2 and prostate neoplasm.